New Player in the Electric Vehicle (EV) Market?
Principal Solar (PSWW) Highlights one of it's Portfolio Holdings, eTruck Transportation.
Alternative Energy...
Institutional Analyst: Our #1 Internet Company, Society Pass (Nasdaq: SOPA), Holds Appeal for Both...
Press Release:
February 28, 2023 07:30 ET | Source: Society Pass Incorporated
New York,...
New Report: Society Pass (SOPA), Our #1 Internet Company Trading Under $5.00.
Our #1 Internet Company Trading Under $5.00, Society Pass Holds Appeal for Both Traders and Long-Term Investors.
Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next Success Story in...
New Report on Revive Therapeutics (RVVTF, RVV). Ushering in Advances in Anti-Inflammatory and Antioxidant Drugs, as a Tool Against Covid.
Society Pass (SOPA) Research Reports
RESEARCH REPORT ARCHIVE
December 27th, 2023. Litchfield Hills Research - $4.00 Price Target.
Initiating Coverage on Society Pass (SOPA).
Institutional Analyst: Society Pass (Nasdaq: SOPA) - Acquiring and Incubating Startups in the Heart of the Asian Silicon Valley
Adding Vaccinex (VCNX) $5.50, to Watch List After Investor Presentation.
IPO Tumbles in Aftermarket, from $12 underwritten by Oppenheimer, BTIG and Ladenburg Thalmann, to a low of $3 in six months.
Short Squeeze Alert.
Internet Stock Review Adds Ebix (EBIX) $39 to Watch List. Short Squeeze Coming? Price Target $110.
Biotech Stock Review Adding PetVivo (PETV) $0.23 to the Watch List.
Are We Catching a Falling Knife?
Don't Think So!
LIVE QUOTE
Added to Watch List $1.32, Dyadic Inc (DYAI) Announces $5 Million Stock Buyback.
CLICK TO VIEW REPORT
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
